Why Patients Choose Penn Medicine
Extraordinary patient care is the number one priority of Penn's Division of Hematology/Oncology. Patients and their physicians choose Penn because:
- Penn hematologists/oncologists are board-certified specialists who are nationally and internationally renowned for their clinical care, research and education.
- Penn hematologists/oncologists are part of multidisciplinary teams of physicians, nurses and support staff from across clinical services who work together to treat the whole patient with individualized treatment plans.
- Penn Hematology/Oncology is part of Penn's Abramson Cancer Center, a comprehensive cancer treatment cancer as designated by the National Cancer Institute and rated as "exceptional" in its most recent peer review.
- Penn's Bone Marrow and Stem Cell Transplant Program is one of the oldest and largest programs in the country, performing the most procedures in the Philadelphia region.
- Penn's hematologists/oncologists are at the forefront of medicine, teaching the next generation of leaders, and developing promising treatment options for tomorrow.
- Penn has dedicated in-patient and out-patient hematology/oncology units staffed with nurses, nurse practitioners and physician assistants experienced in caring for patients with cancer and blood-related disorders.
- Penn hematologists/oncologists are pioneers in the use of alternate bone marrow stem cell donors both from mismatched sibling and unrelated volunteers.
- Penn hematologists/oncologists continue to investigate new treatments for cancer and blood-related disorders and bring these novel therapies directly to patients.
- Penn faculty members serve as medical advisors for area outreach organizations such as the Multiple Myeloma Networking Group, the Leukemia and Lymphoma Society, and Melanoma Research Foundation, and have received numerous awards for their outstanding patient support activities.